Insider Buying: Bonk (NASDAQ:BNKK) Director Purchases 7,500 Shares of Stock

Bonk, Inc. (NASDAQ:BNKK) Director Mitchell Austin Rudy purchased 7,500 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The shares were purchased at an average cost of $1.56 per share, for a total transaction of $11,700.00. Following the completion of the purchase, the director owned 73,341 shares in the company, valued at $114,411.96. This trade represents a 11.39% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Mitchell Austin Rudy also recently made the following trade(s):

• On Tuesday, June 16th, Mitchell Austin Rudy acquired 2,500 shares of Bonk stock. The stock was purchased at an average cost of $1.32 per share, with a total value of $3,300.00.
• On Wednesday, June 10th, Mitchell Austin Rudy acquired 12,000 shares of Bonk stock. The shares were purchased at an average price of $1.37 per share, with a total value of $16,440.00.
• On Thursday, April 9th, Mitchell Austin Rudy acquired 31,055 shares of Bonk stock. The shares were purchased at an average price of $2.82 per share, with a total value of $87,575.10.

Bonk Stock Performance

Shares of NASDAQ:BNKK remained flat at $1.54 during trading on Tuesday. The stock had a trading volume of 156,650 shares, compared to its average volume of 898,779. Bonk, Inc. has a one year low of $1.25 and a one year high of $46.90. The stock has a fifty day moving average price of $2.13 and a two-hundred day moving average price of $3.06. The stock has a market capitalization of $12.32 million, a price-to-earnings ratio of -0.33 and a beta of 1.86.

Bonk (NASDAQ:BNKK) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share (EPS) for the quarter. The business had revenue of $0.79 million during the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%.

Hedge Funds Weigh In On Bonk

Several hedge funds have recently modified their holdings of BNKK. State Street Corp bought a new position in shares of Bonk in the fourth quarter valued at approximately $33,000. Steward Partners Investment Advisory LLC purchased a new stake in shares of Bonk during the fourth quarter valued at approximately $37,000. Jane Street Group LLC bought a new stake in Bonk during the fourth quarter worth $96,000. Finally, Geode Capital Management LLC bought a new stake in Bonk during the fourth quarter worth $128,000. Institutional investors own 12.55% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on BNKK. Wall Street Zen lowered Bonk from a “hold” rating to a “sell” rating in a research report on Sunday. Weiss Ratings lowered shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, April 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.